Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohito Okano

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Diagnostics (Basel, Switzerland)|October 16, 2024
Transforming Lung Cancer Management: A Promising Case Study of Immune Checkpoint Inhibitor Success Following a Multidisciplinary ApproachTadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, et al.
Respiratory Medicine Case Reports|April 16, 2025
Endobronchial tuberculosis mimicking malignancy: Lessons from a case reportTomohito Okano, Hajime Fujimoto, Toshiyuki Ito, et al.
The American Journal of Case Reports|January 8, 2025
Radiological and Pathological Analysis of Pembrolizumab-Associated Lung Lesions: Diagnostic Challenges and ManagementTomohito Okano, Hajime Fujimoto, Toshiyuki Ito, et al.
Cancers|June 24, 2022
Is the Efficacy of Adding Ramucirumab to Docetaxel Related to a History of Immune Checkpoint Inhibitors in the Real-World Clinical Practice?Tadashi Nishimura, Hajime Fujimoto, Tomohito Okano, et al.
Thoracic Cancer|February 15, 2021
Second-line therapy with first- or second-generation tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer patients with T790M-negative or unidentified mutationTadashi Nishimura, Tomohito Okano, Masahiro Naito, et al.
World Journal of Clinical Cases|August 27, 2021
Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: A case reportTadashi Nishimura, Tomohito Okano, Masahiro Naito, et al.
International Journal of Molecular Sciences|March 6, 2019
Protein S is Protective in Acute Lung Injury by Inhibiting Cell ApoptosisPrince Baffour Tonto, Taro Yasuma, Tetsu Kobayashi, et al.
Cancers|October 24, 2020
De Novo T790M Mutation in an L858R Epidermal Growth Factor Receptor Mutant-Associated Lung AdenocarcinomaTakumi Fujiwara, Tetsu Kobayashi, Taro Yasuma, et al.
Advances in Respiratory Medicine|May 27, 2026
Antifibrotic Drugs Regulate the Expression of Epithelial Sodium Channels in the LungsToshiyuki Ito, Hajime Fujimoto, Masaaki Toda, et al.
International Journal of Molecular Sciences|April 13, 2023
Amelioration of Pulmonary Fibrosis by Matrix Metalloproteinase-2 OverexpressionRyo Inoue, Taro Yasuma, Valeria Fridman D'Alessandro, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Diagnostics (Basel, Switzerland)|October 16, 2024
Transforming Lung Cancer Management: A Promising Case Study of Immune Checkpoint Inhibitor Success Following a Multidisciplinary ApproachTadashi Nishimura, Hajime Fujimoto, Takumi Fujiwara, et al.
Respiratory Medicine Case Reports|April 16, 2025
Endobronchial tuberculosis mimicking malignancy: Lessons from a case reportTomohito Okano, Hajime Fujimoto, Toshiyuki Ito, et al.
The American Journal of Case Reports|January 8, 2025
Radiological and Pathological Analysis of Pembrolizumab-Associated Lung Lesions: Diagnostic Challenges and ManagementTomohito Okano, Hajime Fujimoto, Toshiyuki Ito, et al.
Cancers|June 24, 2022
Is the Efficacy of Adding Ramucirumab to Docetaxel Related to a History of Immune Checkpoint Inhibitors in the Real-World Clinical Practice?Tadashi Nishimura, Hajime Fujimoto, Tomohito Okano, et al.
Thoracic Cancer|February 15, 2021
Second-line therapy with first- or second-generation tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer patients with T790M-negative or unidentified mutationTadashi Nishimura, Tomohito Okano, Masahiro Naito, et al.
World Journal of Clinical Cases|August 27, 2021
Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: A case reportTadashi Nishimura, Tomohito Okano, Masahiro Naito, et al.
International Journal of Molecular Sciences|March 6, 2019
Protein S is Protective in Acute Lung Injury by Inhibiting Cell ApoptosisPrince Baffour Tonto, Taro Yasuma, Tetsu Kobayashi, et al.
Cancers|October 24, 2020
De Novo T790M Mutation in an L858R Epidermal Growth Factor Receptor Mutant-Associated Lung AdenocarcinomaTakumi Fujiwara, Tetsu Kobayashi, Taro Yasuma, et al.
Advances in Respiratory Medicine|May 27, 2026
Antifibrotic Drugs Regulate the Expression of Epithelial Sodium Channels in the LungsToshiyuki Ito, Hajime Fujimoto, Masaaki Toda, et al.
International Journal of Molecular Sciences|April 13, 2023
Amelioration of Pulmonary Fibrosis by Matrix Metalloproteinase-2 OverexpressionRyo Inoue, Taro Yasuma, Valeria Fridman D'Alessandro, et al.
Pageof 3